However, the hypnozoiticidal efficacy of current drugs like primaquine and tafenoquine cannot be directly assessed due to the undetectable nature of hypnozoites. Researchers conducted a retrospective ...

cGlobal and Tropical Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, NT, Australia dCentre for Tropical Medicine and Global Health, Nuffield Department of ...

The study (NCT06656351) will evaluate the efficacy and safety of the ARAKODA® regimen (tafenoquine) over 90 days for treating patients with a presumptive diagnosis of chronic babesiosis.

“The Tafenoquine for Babesiosis Expanded Access clinical study may strengthen that hope in a patient population that has few treatment options today. We are pleased to be leading the way in ...

announced the approval of an Investigational Review Board (IRB) for a Phase II clinical study aimed at evaluating the efficacy and safety of tafenoquine, marketed as ARAKODA®, for treating ...

Investigational Review Board (IRB) approval has been granted for the open-label study to evaluate tafenoquine for treatment of patients with a presumptive diagnosis of chronic babesiosis in ...

(SXTPW), a pharmaceutical company specializing in infectious disease treatments, on Wednesday announced the expansion of its clinical trial for tafenoquine, a potential treatment for babesiosis ...

A clinical case series recently published in Clinical Infectious Diseases showed that tafenoquine exhibited an 80 percent cure rate in five high-risk patients with persistent, relapsing babesiosis ...

The following is a summary of “Balanced Solution Versus Normal Saline in Predicted Severe Acute Pancreatitis: A Stepped Wedge Cluster Randomized Trial,” published in the January 2025 issue of Surgery ...